Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for excessive daytime sleepiness in OSAHS
CTR20132530Phase 2Completed
- Sponsor
- Institute of Radiation Medicine, Academy of Military Medical Sciences
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of modafinil in obstructive sleep apnea hypopnea syndrome (OSAHS), Excessive Daytime Sleepiness (EDS), sponsored by Institute of Radiation Medicine, Academy of Military Medical Sciences. Started Feb 2014; status: completed.
02
Drugs
modafinil
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on CTR20132530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132530.